MANUFACTURING FACILITIES ISSUE

MANUFACTURING FACILITIES ISSUE was reported 11 times

MANUFACTURING FACILITIES ISSUE is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Recombinant Human Deoxyribonuclease 1 [EPC] 1 0.0001
1 Aminoglycoside Antibacterial [EPC] 1 0.0000
2 Platinum-based Drug [EPC] 1 0.0000
3 Angiotensin 2 Receptor Blocker [EPC] 1 0.0000
4 HMG-CoA Reductase Inhibitor [EPC] 1 0.0000
5 Atypical Antipsychotic [EPC] 1 0.0000
6 Benzodiazepine [EPC] 1 0.0000